Literature DB >> 9590419

Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians.

K Bersentes1, R Fass, S Padda, C Johnson, R E Sampliner.   

Abstract

Barrett's esophagus (BE) is considered to be a disease of white males with a prevalence ranging from 0.5 to 4.0% in patients undergoing upper endoscopy (EGD) for any indication, and from 12 to 15% in patients with gastroesophageal reflux disease (GERD). The prevalence of BE in Hispanics is not known, but it is assumed to be lower. The aims of this study were to determine the prevalence of BE in Hispanic patients and to compare demographic and endoscopic characteristics with Caucasian patients with BE. Records of patients undergoing an EGD between October 1993 and October 1996 were retrospectively reviewed. Patients were included in the study only if they had columnar-appearing esophageal mucosa at endoscopy and intestinal metaplasia with Alcian blue-staining goblet cells on biopsy. An extensive chart review was performed in patients with BE. There were 75 new cases of BE discovered: 60 (80%) were Caucasians, 6 (8%) Hispanics, 1 (1.4%) Native American, and 8 (10.6%) patients with either unknown or unconfirmed ethnicity. Of the 75 patients, 74 male, and the mean age was 65 +/- 11.4 years (range 36-92 years). The prevalence of BE in Caucasians and Hispanics undergoing EGD for any reason was similar (5.3% and 3.8%, respectively, P = 0.563). The prevalence of BE in patients presenting with GERD symptoms was also similar between Caucasians and Hispanics (25% and 16%, respectively, P = 0.304). The two groups did not differ significantly with respect to age, symptoms, habits, or endoscopic findings. In conclusion, the prevalence of BE among Hispanic patients is similar to Caucasian patients, an unexpected finding.

Entities:  

Mesh:

Year:  1998        PMID: 9590419     DOI: 10.1023/a:1018834902694

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium.

Authors:  A J Cameron; C T Lomboy
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

2.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

Review 3.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  The columnar-lined esophagus (Barrett syndrome)--an acquired condition?

Authors:  S M Mossberg
Journal:  Gastroenterology       Date:  1966-05       Impact factor: 22.682

5.  Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE).

Authors: 
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

6.  Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected.

Authors:  C Yeh; C T Hsu; A S Ho; R E Sampliner; R Fass
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

7.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Barrett's esophagus. Comparison of benign and malignant cases.

Authors:  D B Skinner; B C Walther; R H Riddell; H Schmidt; C Iascone; T R DeMeester
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

9.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

10.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.

Authors:  M G Sarr; S R Hamilton; G C Marrone; J L Cameron
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  8 in total

1.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

2.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy.

Authors:  Julian A Abrams; Sydney Fields; Charles J Lightdale; Alfred I Neugut
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-11       Impact factor: 11.382

4.  Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.

Authors:  D A Corley; A Kubo; T R Levin; G Block; L Habel; G Rumore; C Quesenberry; P Buffler
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

5.  Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender.

Authors:  Xinqing Fan; Ned Snyder
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

Review 6.  Barrett's oesophagus: optimal strategies for prevention and treatment.

Authors:  Ronnie Fass; Richard E Sampliner
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium.

Authors:  Amy Wang; Nora C Mattek; Jennifer L Holub; David A Lieberman; Glenn M Eisen
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

8.  Changing pattern of esophageal cancer incidence in New Mexico: a 30-year evaluation.

Authors:  Kenneth J Vega; M Mazen Jamal; Charles L Wiggins
Journal:  Dig Dis Sci       Date:  2009-08-18       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.